Back to top

ELVN Maintained by Stifel -- Price Target Raised to $80

ELVN Maintained by Stifel -- Price Target Raised to $80

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)